• Product nameAnti-CEP290 antibody
    See all CEP290 primary antibodies
  • Description
    Rabbit polyclonal to CEP290
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse
  • Immunogen

    Synthetic peptide derived from the internal region of Human CEP290.

  • Positive control
    • K562 cell extract.


Associated products


Our Abpromise guarantee covers the use of ab110053 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Predicted molecular weight: 290 kDa.


  • FunctionActivates ATF4-mediated transcription. Required for the correct localization of ciliary and phototransduction proteins in retinal photoreceptor cells; may play a role in ciliary transport processes.
  • Tissue specificityUbiquitous. Expressed strongly in placenta and weakly in brain.
  • Involvement in diseaseDefects in CEP290 are a cause of Joubert syndrome type 5 (JBTS5) [MIM:610188]. Joubert syndrome is an autosomal recessive disease characterized by cerebellar vermis hypoplasia with prominent superior cerebellar peduncles (the 'molar tooth sign' on axial magnetic resonance imaging), psychomotor delay, hypotonia, ataxia, oculomotor apraxia and neonatal breathing abnormalities. JBTS5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.
    Defects in CEP290 are a cause of Senior-Loken syndrome type 6 (SLSN6) [MIM:610189]. Senior-Loken syndrome is also known as juvenile nephronophthisis with Leber amaurosis. It is an autosomal recessive renal-retinal disorder, characterized by progressive wasting of the filtering unit of the kidney, with or without medullary cystic renal disease, and progressive eye disease.
    Defects in CEP290 are the cause of Leber congenital amaurosis type 10 (LCA10) [MIM:611755]. LCA designates a clinically and genetically heterogeneous group of childhood retinal degenerations, generally inherited in an autosomal recessive manner. Affected infants have little or no retinal photoreceptor function as tested by electroretinography. LCA represents the most common genetic cause of congenital visual impairment in infants and children.
    Defects in CEP290 are the cause of Meckel syndrome type 4 (MKS4) [MIM:611134]. MKS4 is an autosomal recessive disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.
    Note=Antibodies against CEP290 are present in sera from patients with cutaneous T-cell lymphomas, but not in the healthy control population.
    Defects in CEP290 are the cause of Bardet-Biedl syndrome type 14 (BBS14) [MIM:209900]. A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for disease manifestation in some cases (triallelic inheritance).
  • Cellular localizationCytoplasm > cytoskeleton > centrosome. Nucleus. Cell projection > cilium. Connecting cilium of photoreceptor cells, base of cilium in kidney intramedullary collecting duct cells.
  • Information by UniProt
  • Database links
  • Alternative names
    • 3H11AG antibody
    • Bardet-Biedl syndrome 14 protein antibody
    • BBS14 antibody
    • Cancer/testis antigen 87 antibody
    • CE290_HUMAN antibody
    • Centrosomal protein 290kDa antibody
    • Centrosomal protein of 290 kDa antibody
    • Cep290 antibody
    • CT87 antibody
    • CTCL tumor antigen se2 2 antibody
    • FLJ13615 antibody
    • FLJ21979 antibody
    • JBTS5 antibody
    • JBTS6 antibody
    • KIAA0373 antibody
    • LCA10 antibody
    • Meckel syndrome, type 4 antibody
    • MKS4 antibody
    • Monoclonal antibody 3H11 antigen antibody
    • Nephrocystin 6 antibody
    • Nephrocystin-6 antibody
    • NPHP6 antibody
    • POC3 antibody
    • POC3 centriolar protein homolog antibody
    • Prostate cancer antigen T21 antibody
    • rd16 antibody
    • SLSN6 1, 2, 5 antibody
    • SLSN6 antibody
    • Tumor antigen se2-2 antibody
    see all

Anti-CEP290 antibody images

  • All lanes : Anti-CEP290 antibody (ab110053) at 1/500 dilution

    Lane 1 : K562 cell extract
    Lane 2 : K562 cell extract with immunising peptide at 10 µg

    Lysates/proteins at 30 µg per lane.

    Predicted band size : 290 kDa

References for Anti-CEP290 antibody (ab110053)

ab110053 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab110053.
Please use the links above to contact us or submit feedback about this product.